2020
Prenatal Treatment of Congenital Cytomegalovirus With Valganciclovir: A Case Report
DeNoble AE, Saccoccio FM, Permar SR, Hughes BL. Prenatal Treatment of Congenital Cytomegalovirus With Valganciclovir: A Case Report. Clinical Infectious Diseases 2020, 71: 2506-2508. PMID: 32198512, DOI: 10.1093/cid/ciaa305.Peer-Reviewed Original ResearchConceptsCommon congenital infectionCongenital CMV infectionCases of hydropsCongenital cytomegalovirusCongenital infectionCMV infectionNeonatal treatmentNeurologic injuryCCMV infectionInfectious causesCase reportFetal anomaliesPrenatal treatmentTreatment strategiesMinimal sequelaeCytomegalovirusInfectionValganciclovirTreatmentSequelaeHydropsPregnancyInjury
2015
Controversies in the Management of Isolated Congenital Atrioventricular Block
DeNoble AE, Kuller JA, Rhee EJ. Controversies in the Management of Isolated Congenital Atrioventricular Block. Obstetrical & Gynecological Survey 2015, 70: 518-523. PMID: 26314237, DOI: 10.1097/ogx.0000000000000208.Peer-Reviewed Original ResearchConceptsCongenital atrioventricular blockAnti-La antibodiesAtrioventricular blockIntravenous immunoglobulinFetuses of mothersStudy of dexamethasoneTreatment of fetusesLarge prospective studiesHigh fetal morbidityPotential adverse effectsRheumatologic symptomsAnti-RoFetal morbidityAntinuclear antibodiesFetal hydropsProspective studyTreatment regimensAutoimmune diseasesRisk mothersLimited potential benefitsAdverse effectsFetusesConflicting resultsAntibodiesTreatment